Advanced Search

 

Study ID Status Title Patient Level Data
Sn408D/06 Completed Assessment of efficacy and safety of Serevent™ Diskus™plus Flutide (Flixotide)™ Diskus™ combination therapy for adult bronchial asthma
SNA10001 Completed A randomised, double blind, placebo controlled, three-way cross-over study in asymptomatic patients with seasonal allergic rhinitis to compare the effect of 7 days treatment with intranasal salmeterol/fluticasone propionate combination ( 100mcg/200mcg) with 7 days treatment of fluticasone propionate (200mcg) or placebo, on nasal clinical symptoms and nasal blockage following intranasal allergen challenge. Study Listed on ClinicalStudyDataRequest.com
SND 103285 Completed A Ten-Week, Multicenter, Randomized, Double-Blind, Placebo and Active-Controlled, Parallel-Group, Flexible-Dose Study Evaluating the Efficacy, Safety, and Tolerability of GSK372475 (1.5 mg/day to 2.0 mg/day) or Extended Release Venlafaxine XR (150 mg/day to 225 mg/day) Compared to Placebo in adult s
SND 103288 Completed A Ten-week, Multicenter, Randomized, Double-Blind, Placebo-and Active-Controlled, Paralleled-Group, Flexible-Dose study Evaluating the Efficacy, Safety and Tolerability of GSK372475 or Paroxetine Compared to Placebo in Adult Subjects Diagnosed with Major Depressive Disorder
SNS-D920619 Completed Serevent Nationwide Surveillance (SNS) Trial
SPD707-104 Completed A study to evaluate immunogenicity, safety and tolerance of three formulations of Fluviral®S/F influenza vaccine and Vaxigrip® in healthy adults 50-64 years of age and 65 years of age or older
SPE111154 Completed A single blind, randomised, placebo controlled, single ascending dose study to evaluate the safety, tolerability and pharmacokinetics of GSK958108 in healthy male subjects
S-RHS00289 Completed An Open-Label, Single-Dose and Multi-Dose Pharmacokinetic Study of 2mg and 4mg Nicotine Lozenge in Chinese Smokers
SRT-501-006 Completed A placebo-controlled pharmacokinetic and safety study of twice daily SRT501 in type 2 diabetic human male subjects Study Listed on ClinicalStudyDataRequest.com
STA106711 Completed Imigran STATdose - Japan clinical experience study for self-injection
STQ105938 Completed A Phase II, multi-centre, open-label, randomised study to evaluate the safety, tolerability and pharmacokinetics of oral sitamaquine compared with amphotericin B in the treatment of visceral leishmaniasis caused by L. donovani in endemic areas.
SUM S2BL 25 Completed Subcutaneous sumatriptan in the acute treatment of migraine in patients using dihydroergotamine as prophylaxis.Extensive searching has revealed that no clinical study report is available for this study.
SUM01 Completed A study to evaluate the excretion of a 6mg subcutaneous dose of sumatriptan into breast milk.
SUM10914 Completed A study to investigate intra-subject variability and sex differences in the pharmacokinetics of 100mg sumatriptan following oral dosing.
SUM10922 Completed A study to evaluate the safety, tolerability and pharmacokinetics of sumatriptan (GR43175) following repeat administration intranasally.
SUM10923 Completed A study to assess the pharmacokinetic and pharmacodynamic profile of intranasal sumatriptan at doses of 5 mg, 10 mg and 20 mg.
SUM10931 Completed Evaluation of the pharmacokinetics and safety of ascending oral doses of GR43175C administered to healthy male volunteers.
SUM10933 Completed Tolerance assessment of daily subcutaneous (sc) GR43175C.
SUM10935 Completed Evaluation of the pharmacokinetics and safety of ascending doses of GR43175C administered subcutaneously to healthy male volunteers.
SUM10948 Completed An open, randomised, single-dose, three-way crossover, pilot study investigating the relative bioavailability of two newly formulated fast disintegrating sumatriptan 50mg tablets versus the currently marketed sumatriptan 50mg tablets in healthy volunteers Study Listed on ClinicalStudyDataRequest.com
SUM10950 Completed An open, randomised, four-period crossover study to demonstrate the bioequivalence of fast disintegrating sumatriptan tablets (50 and 100 mg tablets) compared with the currently marketed sumatriptan tablets (50 and 100 mg IMITREX† /IMIGRAN† tablets), in healthy male and female volunteers Study Listed on ClinicalStudyDataRequest.com
SUM10954 Completed An open, randomised, three-period crossover study to demonstrate the bioequivalence of fast disintegrating sumatriptan 100mg tablet compared to the currently marketed sumatriptan 100mg tablet administered immediately after food and the fast disintegrating tablet administered in the fasted state to healthy male and female subjects Study Listed on ClinicalStudyDataRequest.com
SUM10955 Completed An open, randomised, four-period crossover study to investigate the bioavailability of a new orally disintegrating (melt) formulation (ODT) of sumatriptan, with and without water compared to the currently marketed sumatriptan 100mg tablet and also to investigate the effect of food on the ODT formulation, in healthy male and female subjects Study Listed on ClinicalStudyDataRequest.com
SUM10961 Completed An open, randomised, two-period crossover study to demonstrate the bioequivalence of fast disintegrating sumatriptan 100 mg tablet dissolved in water compared to the currently marketed sumatriptan 100 mg tablet administered in the fasted state to healthy male and female subjects Study Listed on ClinicalStudyDataRequest.com
SUM10965 Completed Bioequivalence study between sumatriptan succinate kit product (STATdose™) and ampoule product in healthy Japanese male subjects

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.